People allergic to insect venom need precision medical diagnosis, treatment

Three to 5 percent of the European population is allergic to insect venom, and many of them are at risk of anaphylaxis if they are stung. Some patients do not respond properly to immunotherapy and in some cases the treatment has reduced or no effect at all — which can be fatal. Researchers are now developing artificial allergens and human antibodies in order to enable individualized immunotherapeutic treatment.